Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (SHE:300255)
China · Delayed Price · Currency is CNY 22.50
-0.32 (-1.40%)
Sep 11, 2026, 3:04 PM CST
SHE:300255 Revenue
Hebei Changshan Biochemical Pharmaceutical had revenue of 219.72M CNY in the quarter ending June 30, 2026, a decrease of -5.66%. This brings the company's revenue in the last twelve months to 859.35M, down -9.98% year-over-year. In the year 2025, Hebei Changshan Biochemical Pharmaceutical had annual revenue of 875.13M, down -15.10%.
Revenue (ttm)
859.35M
Revenue Growth
-9.98%
P/S Ratio
24.41
Revenue / Employee
719.72K
Employees
1,194
Market Cap
20.97B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 875.13M | -155.68M | -15.10% |
| Dec 31, 2024 | 1.03B | -379.63M | -26.92% |
| Dec 31, 2023 | 1.41B | -925.79M | -39.63% |
| Jan 1, 2023 | 2.34B | -631.82M | -21.29% |
| Jan 1, 2022 | 2.97B | 604.26M | 25.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.